Alarming Increase in Ciprofloxacin- and Penicillin-Resistant Neisseria gonorrhoeae Isolates in New Delhi, India

ArticleinSex Transm Dis 30(6):523-5 · July 2003with17 Reads
Impact Factor: 2.84 · DOI: 10.1097/00007435-200306000-00010 · Source: PubMed

    Abstract

    Resistance of ciprofloxacin has been reported in several regions of the world, including India. In India, ciprofloxacin is still being used as single-dose treatment for gonorrhea.
    The aim of the study was to determine the antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients with acute gonococcal urethritis in New Delhi.
    By means of disc diffusion, we determined the susceptibility profiles of N gonorrhoeae isolates, determined the MICs of ciprofloxacin, penicillin, and ceftriaxone, and compared our data with previous findings.
    On the basis of MIC values, 35.3% and 52.9% of strains were found to be resistant and less sensitive, respectively, to penicillin; 67.3% and 28.2% strains were observed to be resistant and less sensitive, respectively, to ciprofloxacin. Only one isolate (5.9%) was found to be less sensitive to ceftriaxone.
    The significant increase in ciprofloxacin resistance in the current study indicates that resistance has developed under selective antibiotic pressure.